Apigenin treatment of microglia/C6 co-cultures also induced preferentially a reduction in the viability of C6 cells and increased microglia-activated phenotype, associated with a change in the balance of TNF/IL-10 levels, demonstrating that the flavonoid restores the immune profile of microglia against glioma cells [6]. The gene discussed is IL10; the disease is central nervous system cancer.